ORGANISER


GOLD SPONSOR

 


SILVER SPONSORS


BRONZE SPONSORS

 

Programme

Plenary session, 12 June

Time  
18:30 Welcome by the President
18:40

Celeste Porsbjerg, University of Copenhagen, Denmark

►Asthma - what can we learn from the Danish registries?

19:00

Magnus Sköld, Karolinska Institute, Sweden

►COPD in never-smokers: same COPD or another COPD?

19:20

Marieke van der Werf, European Centre for Disease Prevention and Control, Sweden

►Ending tuberculosis in the Nordic countries

19:40

Martin C. Tammemägi, Brock University, Canada

►Lung Cancer Screening — How to Move Forward?

20:00 Welcome Reception at the congress venue the Tallinn Creative Hub

 

Thursday, 13 June

Time

SESSION 1
Sarcoidosis
-
Chairs: Elizabeth Arkema, Karolinska Institute, Sweden

Kai Kliiman, Tartu University Hospital, Estonia

SESSION 2
Management of early stage lung cancer
-
Chairs: Walter Klepetko, Medical University of Vienna, Austria

Martin C. Tammemägi, Brock University, Canada

SESSION 3
Tuberculosis I ● TB Risk factors and epidemiology
-
Chairs: Marieke van der Werf, European Centre for Disease Prevention and Control, Sweden

Liga Kuksa, Riga Eastern Clinical University Hospital, Latvia

SESSION 4
Nurses’ session I ● Compliance with CPAP treatment
-
Chairs: Airi Toode, North Estonia Medical Centre, Estonia

Erna Sif Arnardottir, Reykjavik University, Iceland

08:30 Elizabeth Arkema, Karolinska Institute, Sweden
►Epidemiology of sarcoidosis: current findings and future directions
Haseem Ashraf, University of Oslo, Norway
►Lung cancer screening – current evidence and application in Nordic countries
Einar Heldal, Norwegian Institute of Public Health, Norway
►Tuberculosis and migration in the Nordic countries - trends, challenges and opportunities
Jenny Theorell-Haglöw, Uppsala University, Sweden
►Nurse’s role in CPAP compliance
09:00 Susanne Gabrielsson, Karolinska Institute, Sweden
►Exosomes as immune regulators in sarcoidosis, asthma and COPD
Karin Lindberg, Karolinska Institute, Sweden
SBRT in early stage NSCLC
Knut Lönnroth, Karolinska Institute, Sweden
►Social determinants and risk factors for TB
Hanna-Riikka Kreivi, University of Helsinki, Finland
►How to improve CPAP compliance – pulmonologist's advice
09:30 Jukka Lehtonen, Helsinki University Central Hospital, Finland
►Cardiac sarcoidosis
Tanel Laisaar, Tartu University Hospital, Estonia
►Minimally invasive surgery for lung cancer – how minimally invasive we can go?
Piret Viiklepp, National Institute for Health Development of Estonia, Estonia
►Estonia – a success story: from high TB burden to low incidence country
Margareta Mökleby, Lovisenberg Diakonale Hospital, Norway
►Patient`s experience of living with obstructive sleep apnea and the use of CPAP
10:00 Coffee Break Coffee Break Coffee Break Coffee Break
  SESSION 5
Non-invasive ventilation
-
Chairs: Eva Lindberg, Uppsala University, Sweden

Rain Jõgi, Tartu University Hospital, Estonia

SESSION 6
Management of advanced stage lung cancer
-
Chairs:
Ingemar Almre, North Estonia Medical Centre, Estonia
Karin Lindberg, Karolinska Institute, Sweden 

SESSION 7
Tuberculosis II ● TB diagnostics and management
-
Chairs: Tuula Vasankari, Finnish Lung Health Association, Finland

Einar Heldal, Norwegian Institute of Public Health, Norway

SESSION 8
Nurses’ session II ● From lung transplantation to pulmonary rehabilitation
-
Chairs: Jonina Sigurgeirsdottir, Reykjalundur Rehabilitation Centre, Iceland

Hõbe Treufeldt, Tartu University Hospital, Estonia

10:30 Eva Lindberg, Uppsala University
►NIV in stable COPD

 
Walter Klepetko, Medical University of Vienna, Austria
►Role of surgery in locally advanced lung cancer – where are the limits?
Judith Bruchfeld, Karolinska Institute, Sweden
►Challenges in diagnostics and management of latent TB Infection (LTBI)
Bodil Ivarsson, Lund University, Sweden
►Nurses’ role in the lung transplantation team
11:00 Ulla Anttalainen, Turku University Hospital, Finland
►Telemonitoring of NIV in COPD

 
Jari Räsänen, Helsinki University Hospital, Finland
►Surgical treatment of oligometastatic lung cancer and lung metastases of other primaries
Hanna Soini, National Institute for Health and Welfare, Finland
►Whole genome sequencing (WGS) in the routine diagnostics of tuberculosis – prediction of drug resistance and genotyping
Hõbe Treufeldt, Tartu University Hospital, Estonia
►Psychologist’s role in the lung transplantation team
 
11:30 Ole Hilberg, Aarhus University, Denmark
►Danish guidelines for home-based NIV

 
Jon Alexander Lykkegaard Andersen, Copenhagen University Hospital, Denmark
►Metastatic lung cancer – how to select proper treatment in the era of immunotherapy and targeted treatment?
Manfred Danilovitš, Tartu University Hospital, Estonia
►New and shorter regimens to treat drug-resistant TB

 
Jonina Sigurgeirsdottir, Reykjalundur Rehabilitation Centre, Iceland
►Rehabilitation and self-management of lung patients
12:00 AstraZeneca Lunch Symposium Lunch Lunch Lunch
 

SESSION 9
Severe asthma
-
Chairs: Celeste Porsbjerg, University of Copenhagen, Denmark

Lauri Lehtimäki, University of Tampere, Finland

SESSION 10
Lung transplantation
-
Chairs: Are Martin Holm, University of Oslo, Norway

Tanel Laisaar, Tartu University Hospital, Estonia

SESSION 11
Oral presentations I
-
Chairs: Ott Kiens, Tartu University Hospital, Estonia

SESSION 12
Nurses’ session III ● Breathlessness, NIV and teleconsultations
-
Chairs: Kristiina Saksniit, Tartu University Hospital, Estonia

Anne Dichmann Sorknæs, University of Southern Denmark, Denmark

13:00 Alan Altraja, University of Tartu, Estonia
►Severe asthma in the Nordics: Highlights from the Nordic Severe Asthma Consensus Statement 2018
Walter Klepetko, Medical University of Vienna, Austria
►How to select a patient for lung transplantation?

Anne Orholm Nielsen, Denmark
►β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease – a Danish Nationwide study of 1.3 million individuals

Simen Alexander Steindal, Lovisenberg Diaconal University College, Norway
►Effectiveness of nursing interventions to manage breathlessness in COPD

Christer Janson, Sweden
►Oral corticosteroids exposure in a Swedish nationwide asthma population during 2006-2016

13:30 Hannu Kankaanranta, University of Tampere, Finland
►Asthma beginning at adult age – not a rare disease
Are Martin Holm, University of Oslo, Norway
►Long term outcome of lung transplantation – does the diagnosis matter?

Virve Korhonen, Finland
►Predictors for tuberculosis treatment outcomes in Finland 2007-2014

Kristiina Saksniit, Tartu University Hospital, Estonia
►Performing NIV in the pulmonary department

Camilla Udjus, Norway
►Reduced hypoxia-induced pulmonary hypertension and smooth muscle cell proliferation in caspase-1 deficiency

14:00 Vibeke Backer, Bispebjerg University Hospital, Denmark
►Novel treatments for severe asthma: Recently arrived, and in the pipeline
Stig Steen, Lund University, Sweden
►Ex-vivo lung perfusion – current role and future perspectives
 

Virginija Kalinauskaitė-Žukauskė, Lithuania
►Effect of single-dose of mepolizumab on blood eosinophil count, FeNO, FEV1 and bronchial epithelial-derived mediators in severe non-allergic eosinophilic asthma

Anne Dichmann Sorknæs, Lovisenberg Diaconal University College, Denmark
►Nurses’ experience on pulmonary teleconsultations

Per Wollmer, Sweden
►In vivo morphometry of the distal airspaces in humans

14:30 Coffee Break and poster session I on 0 floor
 

SESSION 13
Pulmonary hypertension ●Risk Stratification in Pulmonary Arterial Hypertension following WSPH 2018 - patient case illustrations
-
Chairs: Göran Rådegran, Skåne Univeristy Hospital, Sweden

Kaija Tammekivi, Tartu University Hospital, Estonia

SESSION 14
New methods in interventional pulmonology
-
Chairs: Toomas Uibu, Tampere University Hospital, Finland

Pille Mukk, North Estonia Medical Center, Estonia

SESSION 15
Respiratory epidemiology in Nordic countries
-
Chairs: Christer Janson, Uppsala University, Sweden

Rain Jõgi, Tartu University Hospital, Estonia
 

SESSION 16
Nurses’ session IV ● Palliative care for respiratory patients
-
Chairs: Helga Jónsdóttir, University of Iceland, Iceland

Carine Gross, Tartu University Hospital, Estonia

15:00 Göran Rådegran, Skåne University hospital, Sweden
►Risk Assessment in treatment and follow up of PAH patients following WSPH in Nice 2018
 
Jukka Randell, Kuopio University Hospital, Finland
►Cryobiopsies in diffuse parenchymal lung diseases. Results of a multicenter study

 
Christer Janson, Uppsala University, Sweden
►Respiratory Health in Northern Europe



 
Bryndis Halldorsdottir, Landspitali University Hospital, Iceland
►Nursing care for patients dependent on mechanical ventilation
15:30 Clara Hjalmarsson, Sahlgrenska University Hospital, Sweden
►Impact of age and comorbidities for prognosis in PAH
 
Michael Perch, Copenhagen University Hospital, Denmark
►Bronchoscopic treatment of pulmonary emphysema
 
Arnulf Langhammer, Norwegian University of Science and Technology, Norway
►The HUNT study

 
Helga Jónsdóttir, University of Iceland, Iceland
►Palliative care for patients with chronic obstructive pulmonary disease
16:00 Roger Hesselstrand, Skåne University Hospital, Sweden
►Impact of connective tissue disease and comorbidities on outcome in PAH
Toomas Uibu, Tampere University Hospital, Finland
►Photodynamit therapy of intrabronchial tumours
Cecilie Svanes, University of Bergen, Norway
►RHINESSA, the future of respiratory epidemiology
 
Þorbjorg Soley Ingadottir, University of Iceland, Iceland
►Providing palliative care to chronic lung patients
16:30 GlaxoSmithKline Afternoon Symposium Fisher & Paykel Afternoon Symposium

Novartis Afternoon Symposium

Unnur Steina Björnsdóttir

►Severe Asthma & Overview of the Type 1 and Type 2 inflammatory pathways

The Nordic Respiratory Academy (NORA) meeting: in the main congress venue
17:30 Break
17:45   The Nordic Severe Asthma Network (NSAN) meeting: in the main congress venue
20:00 Nordic Lung Congress Dinner at Seaplane Harbour of Estonian Maritime Museum

 

Friday, 14 June

Time

SESSION 17
Updates on pneumonia

-

Chairs: Lars Heggelund, Drammen Hospital, Norway

Ott Kiens, Tartu University Hospital, Estonia

SESSION 18
Hot topics and recent advances in idiopathic pulmonary fibrosis

-

Chairs: Maria Diakopoulou, Karolinska University Hospital Solna Sweden

Kaisa Rajala, Helsinki University Hospital, Finland

SESSION 19
Oral presentations II

-

Chairs: TBC

SESSION 20
Nurses’ session V ● Management of CPAP treatment

-

Chairs: Tarja Saaresranta, University of Turku, Finland

Erla Björnsdottir, University of Iceland, Iceland

09:00

Lars Heggelund, Drammen Hospital, Norway
►Pneumonia pathogenesis and etiology

Maria Diakopoulou, Karolinska University Hospital Solna Sweden
►Acute Exacerbations of idiopathic pulmonary fibrosis

Trine Oksholm, Netherlands
►Changes in Symptom Burden from Before through 12 Months after Lung Cancer Surgery

Marian Petersen, The National University Hospital, Rigshospitalet, Denmark
►Family, social life and CPAP

Emelie Rosèn, Sweden
►Functional Ventilatory Imaging of the Lungs using Computed Tomography – Reference Intervals in Supine middle aged Men and Women
09:30

Jan Cato Holter, Oslo University Hospital, Norway
►Syndrome-based rapid point-of-care detection of respiratory pathogens in pneumonia: Evaluation of a new multiplex PCR panel in a tertiary, regional hospital in Norway

Michael Durheim, Oslo University Hospital, Norway
►Treatment of idiopathic pulmonary fibrosis: the latest advances and future directions

Xingwu Zhou, Sweden
►Assessment of GLI reference equations for diffusing capacity in the Swedish CardioPulmonary BioImage Study (SCAPIS)

Erve Sõõru, North Estonia Medical Centre, Estonia
►Management of sleep apnea among drivers: the Estonian approach

Christer Janson, Sweden
►Propellants for Inhaled Therapy in Sweden – Context and Trends for Carbon Footprint
10:00

William Ward Siljan, Akershus University Hospital, Norway
►Treatment of pneumonia: new developments in the field

Kaisa Rajala, Helsinki University Hospital, Finland
►End of life and palliative care of IPF

Teet Pullerits, Estonia
►One year follow-up of patients with severe eosinophilic asthma treated with mepolizumab: effect on asthma control, FEV1 and FeNO

Erla Björnsdottir, University of Iceland, Iceland
►Insomnia and the effect on CPAP

Össur Ingi Emilsson, Sweden
►Sleep apnea risk associates with lung function decline among asthmatics: The ALEC study
10:30 Coffee Break and poster session II on 0 floor
 

SESSION 21
Sleep-disordered breathing

-

Chairs: Erve Sõõru, North Estonia Medical Centre, Estonia

Jan Hedner, University of Gothenburg, Sweden

SESSION 22
Advances in chest radiology

-

Chairs: (tba)

SESSION 23
Recent guidelines of Idiopathic pulmonary fibrosis

-

Chairs: Venerino Poletti, Aarhus University Hospital, Denmark

Alan Altraja, University of Tartu, Estonia

SESSION 24
Nurses’ session VI ● Tuberculosis

-

Chairs: Sirkku Grierson, Finnish Lung Health Association, Finland

Anu Kurve, North Estonia Medical Centre, Estonia

11:00

Tarja Saaresranta, University of Turku, Finland
►Phenotypes of sleep apnea

Jürgen Biederer, Heidelberg University Hospital, Germany
►Lung MRI

Alan Altraja, University of Tartu, Estonia
►General statements of the new Official ATS-ERS-JRS-ALAT Clinical Practice Guideline

Evita Biraua, Riga East University Hospital, Latvia
►DOTS in Latvia

11:30

Olli Polo, University of Turku, Finland
►Diagnostic methods of sleep disordered breathing

Christian B Laursen, Odense University Hospital, Denmark
►Ultrasound assessment of parenchymal abnormalities

Michael Brun Andersen, Aarhus University hospital, Denmark
►Diagnostic Imaging in the new guidelines and beyond

Sirkku Grierson, Finnish Lung Health Association, Finland
►How we maintain TB awareness in Finland

12:00

Jan Hedner, University of Gothenburg, Sweden
►Non-CPAP therapies in sleep disordered breathing

Andrei Šamarin, North Estonia Medical Centre, Estonia
►Beyond pulmonary sarcoidosis: PET and MR imaging in cardiac involvement

Natalja Sisask, North Estonia Medical Centre, Estonia
►Dual Energy CT imaging in pulmonary embolism

Venerino Poletti, Aarhus University Hospital, Denmark
►Lung biopsy or no lung biopsy – when and why?

Vahur Hollo, National Institute for Health Development, Estonia
►Immigration and tuberculosis

12:30 Boehringer-Ingelheim Lunch Symposium   Networking event – between nurses in the Nordic and Baltic countries
(Duration 12:30-14:30)
 

SESSION 25
Hot topics in lung diseases

-

Chairs: Leif Bjermer, Skåne University Hospital, Sweden

Ott Kiens, Tartu University Hospital, Estonia

SESSION 26
Rare lung diseases

-

Chairs: Elisabeth Bendstrup, Aarhus University Hospital, Denmark

Alan Altraja, University of Tartu, Estonia

SESSION 27
Lifestyle and nutrition in lung diseases

-

Chairs: Pille Mukk, North Estonia Medical Centre, Estonia

Heli Paaliste, North Estonia Medical Centre, Estonia

13:15

Cecilia Andersson, Skåne University Hospital, Sweden
►Mast cells in health and disease

Elisabeth Bendstrup, Aarhus University Hospital, Denmark
►Pulmonary alveolar proteinosis: epidemiology, current state of art and new hopes for treatment

Annemie Schols, Maastricht University, Netherlands
►Wasting in chronic respiratory diseases and the impact of disease exacerbations

13:30

Leif Bjermer, Skåne University Hospital, Sweden
►Update on personalized medicine in Obstructive airway disease

Åsa Lina Jönsson, Aarhus University, Denmark
►Pulmonary alveolar microlithiasis: a basic, translational and clinical update

Annika Reintam Blaser, Lucerne Cantonal Hospital, Switzerland
►Clinical nutrition in intensive care unit

14:00

Jonas Erjefält, Lund University, Sweden
►Biomarkers reflecting tissue inflammation

Saher Shaker, Herlev-Gentofte Hospital, Denmark
►Pleuroparenchymal fibroelastosis: a not that rare condition to revisit

Hanna-Liis Lepp, North Estonia Medical Centre, Estonia
►Clinical Nutrition in Multidisiplinary Management of Pulmonary Patients

14:30 Poster/oral presentation awards. Closing remarks  
15:00 Farewell